Eupraxia Pharmaceuticals Q2 EPS $(0.23) Beats $(0.25) Estimate
Eupraxia Pharmaceuticals (TSX:EPRX) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.25) by 8 percent. This is a 11.54 percent increase over losses of $(0.26) per share
Eupraxia lost less money than people expected this quarter, and it's losing less money over time too. When a company loses money but loses *less* than thought, that's a sign things might be heading in a better direction.
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.